RNA

Total RNA was prepared from cell line WM46. WM46 is a metastatic human melanoma cell line that displays a pigmented fibroblastic morphology. This cell line was established from left chest & abdomen in a 43-year-old female patient with level IV superficial spreading melanoma and a tumor thickness of 1.44. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses PTEN loss of function including hemizygous deletion, and R24C mutation at position 24 in the CDK4 gene. The R24C mutation results in an amino acid substitution at codon 24 in CDK4, from an arginine (R) to cysteine (C). This mutation abolishes the ability of CDK4 to bind to p16(INK4a). WM46 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM46. WM46 is a metastatic human melanoma cell line that displays a pigmented fibroblastic morphology. This cell line was established from left chest & abdomen in a 43-year-old female patient with level IV superficial spreading melanoma and a tumor thickness of 1.44. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses PTEN loss of function including hemizygous deletion, and R24C mutation at position 24 in the CDK4 gene. The R24C mutation results in an amino acid substitution at codon 24 in CDK4, from an arginine (R) to cysteine (C). This mutation abolishes the ability of CDK4 to bind to p16(INK4a). WM46 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM51. WM51 is a metastatic human melanoma cell line that was established from a metastatic tissue site of a male patient. These cells display a mixed morphology and require sub-confluent culture conditions. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM51 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM51. WM51 is a metastatic human melanoma cell line that was established from a metastatic tissue site of a male patient. These cells display a mixed morphology and require sub-confluent culture conditions. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM51 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM51. WM51 is a metastatic human melanoma cell line that was established from a metastatic tissue site of a male patient. These cells display a mixed morphology and require sub-confluent culture conditions. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM51 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM75. WM75 is a metastatic human melanoma cell line that displays pigmented morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type PTEN, N-RAS, c-KIT, and CDK4 genes. WM75 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM75. WM75 is a metastatic human melanoma cell line that displays pigmented morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type PTEN, N-RAS, c-KIT, and CDK4 genes. WM75 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM75. WM75 is a metastatic human melanoma cell line that displays pigmented morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type PTEN, N-RAS, c-KIT, and CDK4 genes. WM75 cells produce xenograft tumors when injected into immunocompromised mice.

Total RNA was prepared from cell line WM8. WM8 is a metastatic human melanoma cell line. This cell line features the specific N818K mutation in the c-KIT gene. This cell line expresses wild type BRAF, PTEN, N-RAS, and CDK4 genes. WM8 cells produce xenograft tumors when injected into immunocompromised mice.